Low dose oral haloperidol does not prolong QTc interval in older acutely hospitalised adults: a subanalysis of a randomised double-blind placebo-controlled study

Autor: Schrijver, Edmée Jm, Verstraaten, Maaike, van de Ven, Peter M, Bet, Pierre M, van Strien, Astrid M, de Cock, Carel, Nanayakkara, Prabath Wb

Publikováno v: Journal of Geriatric Cardiology, 15(6), 401-407. Science Press
Schrijver, E J, Verstraaten, M, van de Ven, P M, Bet, P M, van Strien, A M, de Cock, C & Nanayakkara, P W 2018, ' Low dose oral haloperidol does not prolong QTc interval in older acutely hospitalised adults : a subanalysis of a randomised double-blind placebo-controlled study ', Journal of Geriatric Cardiology, vol. 15, no. 6, pp. 401-407 . https://doi.org/10.11909/j.issn.1671-5411.2018.06.003

Background: Haloperidol is the most frequently prescribed antipsychotic for delirium symptoms. The risk of QTc prolongation often raises concerns, although the effect of haloperidol on QTc interval has not yet been investigated in a randomised placeb

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::d913331ccf0e341aef201807bc7505a0
https://research.vumc.nl/en/publications/b06a2d56-d593-48a0-8283-abb22fa366c2